43 results
424B5
BCLI
Brainstorm Cell Therapeutics, Inc.
19 Jul 23
Prospectus supplement for primary offering
9:28am
by our stockholders, or otherwise harm our reputation. If material weaknesses are identified in the future, it could be costly to remediate
8-K
EX-10.1
9q27 0gp7gkp
3 Sep 20
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
qe8qz ro5y
3 Apr 20
Departure of Directors or Certain Officers
5:00pm
424B1
i4dizk
10 Feb 15
Prospectus with pricing info
12:00am
424B1
zplsh
10 Feb 15
Prospectus with pricing info
12:00am
S-3
0iqnae ag
26 Jan 15
Shelf registration
12:00am
S-3
s11za3oo3k8ojgjc2
26 Jan 15
Shelf registration
12:00am